Bonnez Quintijn, Legan Emily R, Pareyn Inge, Boudry Febe, Anckaert Jennifer, Tersteeg Claudia, De Meyer Simon F, Li Renhao, Vanhoorelbeke Karen
Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.
Blood Adv. 2025 Apr 22;9(8):1763-1771. doi: 10.1182/bloodadvances.2024014950.
Allosteric regulation of ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type-1 motif, member 13) activity involves an interaction between its spacer (S) and 2 complement C1r/C1s, Uegf and BMP1 (CUB; CUB1-2) domains to keep the enzyme in a closed, latent conformation. Monoclonal antibodies (mAbs) uncouple the S-CUB interaction to open the ADAMTS13 conformation and thereby disrupt the global enzyme latency. The molecular mechanism behind this mAb-induced allostery remains poorly understood. To gain insights in the mAb-induced S-CUB uncoupling and global latency disruption, we combined hydrogen/deuterium exchange mass spectrometry (HDX-MS) with structural analysis of ADAMTS13 CUB1-2 mutants. Thereby, the CUB1 L3 and L9 loops were fine-mapped as the 17G2 mAb binding epitope. Indirect S-CUB uncoupling was observed as mAb binding-induced extensive structural dynamics within both CUB1-2 domains without directly targeting the contiguous CUB1 surface that engages with the ADAMTS13 S domain. HDX-MS analysis revealed the short interdomain linker to structurally cover the central CUB1-2 domain interface, which also showed some protein regions that became more exposed upon mAb binding. Therefore, repositioning of the central CUB1-2 interface appears crucial to transfer structural dynamics between both domains. Nevertheless, mutagenesis of the short linker did not disrupt the ADAMTS13 global latency because its closed conformation was preserved. Presumably, allosteric disruption of the global latency requires a structural impact extending beyond the central interface repositioning. Because anti-ADAMTS13 autoantibodies from patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) also induce an open ADAMTS13 conformation, our novel insights in the antibody-mediated global latency disruption boost our understanding of the iTTP disease pathology.
ADAMTS13(含血小板反应蛋白基序的解聚素和金属蛋白酶13)活性的变构调节涉及其间隔区(S)与2个补体C1r/C1s、Uegf和BMP1(CUB;CUB1-2)结构域之间的相互作用,以使该酶保持封闭的潜伏构象。单克隆抗体(mAb)可解开S-CUB相互作用,从而打开ADAMTS13的构象,进而破坏整体酶的潜伏性。这种mAb诱导的变构背后的分子机制仍知之甚少。为了深入了解mAb诱导的S-CUB解偶联和整体潜伏性破坏,我们将氢/氘交换质谱(HDX-MS)与ADAMTS13 CUB1-2突变体的结构分析相结合。由此,CUB1的L3和L9环被精细定位为17G2 mAb的结合表位。观察到间接的S-CUB解偶联,因为mAb结合诱导了CUB1-2两个结构域内广泛的结构动力学变化,而没有直接靶向与ADAMTS13 S结构域相互作用的相邻CUB1表面。HDX-MS分析表明,短的结构域间连接子在结构上覆盖了中央CUB1-2结构域界面,该界面也显示出一些在mAb结合后变得更加暴露的蛋白质区域。因此,中央CUB1-2界面的重新定位似乎对于在两个结构域之间传递结构动力学变化至关重要。然而,短连接子的诱变并未破坏ADAMTS13的整体潜伏性,因为其封闭构象得以保留。据推测,整体潜伏性的变构破坏需要超出中央界面重新定位的结构影响。由于来自免疫介导的血栓性血小板减少性紫癜(iTTP)患者的抗ADAMTS13自身抗体也诱导ADAMTS13呈开放构象,我们对抗体介导的整体潜伏性破坏的新见解增进了我们对iTTP疾病病理学的理解。